ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,360.79
0.26%
Dow Jones
38,868.04
0.00%
US Dollar vs MXN
18.35301
-1.20%
Brent Oil
81.175
-0.73%
Bitcoin
66,972.75
-3.65%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
11/06/202407:23Business WireCrayon Achieves AWS SaaS Competency, Further Cementing Its Leadership in Cloud Innovation
11/06/202407:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NWBINorthwest Bancshares Inc
11/06/202407:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:INGVFIng Groep NV (PK)
11/06/202407:20Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NASDAQ:OCCIOOFS Credit Company Inc
11/06/202407:20Business WireConsumers Are Crowdsourcing Their Financial Services, While Banks Risk Losing Primary StatusNASDAQ:SOFISoFi Technologies Inc
11/06/202407:20GlobeNewswire Inc.Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal CancerNASDAQ:PCSAProcessa Pharmaceuticals Inc
11/06/202407:20PR Newswire (US)Sunbelt Solomon Announces Acquisition of Valley Transformer
11/06/202407:18PR Newswire (US)SpartanNash Hosts Mass Volunteer Event, Boxing 500,000 Donated Meals for Disaster ReliefNASDAQ:SPTNSpartanNash Company
11/06/202407:18PR Newswire (US)Transifex Announces Transifex AI to Accelerate Enterprise Globalization Strategies
11/06/202407:17GlobeNewswire Inc.Bill C-58 would significantly lower quality of services offered to Canadians, MEI tells Senators
11/06/202407:17PR Newswire (US)True Colors Announces New Tailored Talent Acquisition Program to Empower Businesses in Building Winning Teams
11/06/202407:16Edgar (US Regulatory)Form 8-K - Current reportNYSE:NEENextEra Energy Inc
11/06/202407:16Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:INCYIncyte Corporation
11/06/202407:16Business WireContango ORE Announces Pricing of $15 Million Underwritten Public OfferingAMEX:CTGOContango Ore Inc
11/06/202407:16Business WireValmont Releases 2024 Sustainability ReportNYSE:VMIValmont Industries
11/06/202407:15GlobeNewswire Inc.Rhodian Group Partners with LIBRA Insurance Partners
11/06/202407:15GlobeNewswire Inc.Mizuho Americas Hires Steven Valiquette as Managing Director and Senior Equity Research Analyst to Cover Health Care Technology & Distribution8411.T
11/06/202407:15GlobeNewswire Inc.Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill Haney to Executive Chairman
11/06/202407:15Business WireCoya Therapeutics Announces Publication of ALS Study in Peer-Reviewed Journal Frontiers in NeurologyNASDAQ:COYACoya Therapeutics Inc
11/06/202407:15GlobeNewswire Inc.GMMB Rolls Out First-of-its-kind Ad Buying Tools for 2024 Election Cycle
11/06/202407:15Business WireHigh Alpha Raises $125M Fund, Focused on the Future of Enterprise SaaS
11/06/202407:15PR Newswire (US)NEW FARBERWARE® VIBRANCE™ COOKWARE
11/06/202407:15PR Newswire (US)Marathon Petroleum Corp. to Report Second-Quarter Financial Results on August 6, 2024NYSE:MPCMarathon Petroleum Corporation
11/06/202407:15PR Newswire (US)MPLX LP to Report Second-Quarter Financial Results on August 6, 2024NYSE:MPLXMPLX LP
11/06/202407:15PR Newswire (US)The Vitamin Shoppe Unveils its Top Five Health and Wellness Trends for 2024 in Exclusive Study
11/06/202407:15PR Newswire (US)FutureDial Enhances its World-Class Refurbishment Software: More Customization Options, More Intelligence
11/06/202407:15PR Newswire (US)Private Jet Operator, Thrive Aviation Achieves Prestigious ARGU/US Platinum Elite Safety Rating
11/06/202407:15PR Newswire (US)Coors Spirits Co. Unveils Second Blue Run Micro-Batch Bourbon Release: Blue Run Flight Series II
11/06/202407:15PR Newswire (US)ProImpact Launches Innovative College Mentoring Service to Help Students Get Accepted to Top Colleges and Avoid the College Debt Trap
11/06/202407:13Business WireInterSystems and CLEAR Partner to Transform the Patient and Provider Experience with Enhanced Identity Verification Technology

Su Consulta Reciente

EU
ATIA
21Shares
BIT
P1VER3
NLBNPIT1VER3 20991231 0....
BIT
P1TTC7
NLBNPIT1TTC7 20240621 2.8
BIT
P20DK4
NLBNPIT20DK4 20991231 31...
BOV
PATI4
PANATLANTICA PN
BIT
P1NBA2
BNP Paribas Issuance
BIT
P1PKI1
BNP Paribas Issuance
BIT
P1ZDQ8
NLBNPIT1ZDQ8 20240621 170
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados